Siga Technologies INC Cost of Revenue
Siga Technologies INC (SIGA) reported Cost of Revenue of $130.00 thousand for the 3-month period ending 2019-12-31, per its 10-K filed 2020-03-05.
Discontinued › Expense Statement
us-gaap:CostOfRevenue · last filed 2020-03-05
- Siga Technologies INC cost of revenue for the quarter ending 2019-12-31 was $130.00K, a 26.21% increase year-over-year.
- Siga Technologies INC cost of revenue for the quarter ending 2019-09-30 was $737.00K, a 99.23% decline year-over-year.
- Siga Technologies INC cost of revenue for the quarter ending 2019-06-30 was $0.00.
- Siga Technologies INC cost of revenue for the quarter ending 2019-03-31 was $915.00K.
- Siga Technologies INC cost of revenue for fiscal 2019 was $1.78M, a 98.13% decline from fiscal 2018.
- Siga Technologies INC cost of revenue for fiscal 2018 was $95.27M.
- Siga Technologies INC cost of revenue for fiscal 2017 was $0.00.
- Siga Technologies INC cost of revenue for fiscal 2016 was $0.00.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $130.00K 10-K · filed 2020-03-05 | $867.00K derived: sum of 2 quarters · filed 2020-03-05 | $867.00K derived: sum of 3 quarters · filed 2020-03-05 | $1.78M 10-K · filed 2020-03-05 | |
| 2019-09-30 | $737.00K 10-K · filed 2020-03-05 | $737.27K 10-Q · filed 2019-11-05 | $737.00K derived: sum of 2 quarters · filed 2020-03-05 | $1.65M 10-Q · filed 2019-11-05 | $1.75M derived: sum of 4 quarters · filed 2020-03-05 |
| 2019-06-30 | $0.00 10-K · filed 2020-03-05 | $915.37K 10-Q · filed 2019-08-06 | $1.02M derived: sum of 3 quarters · filed 2020-03-05 | $96.18M derived: sum of 4 quarters · filed 2020-03-05 | |
| 2019-03-31 | $915.00K 10-K · filed 2020-03-05 | $915.37K 10-Q · filed 2019-05-02 | $1.02M derived: sum of 2 quarters · filed 2020-03-05 | $96.18M derived: sum of 3 quarters · filed 2020-03-05 | $96.18M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-12-31 | $103.00K 10-K · filed 2020-03-05 | $95.27M derived: sum of 2 quarters · filed 2020-03-05 | $95.27M derived: sum of 3 quarters · filed 2020-03-05 | $95.27M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $95.17M 10-K · filed 2020-03-05 | $95.17M 10-Q · filed 2018-11-06 | $95.17M derived: sum of 2 quarters · filed 2020-03-05 | $95.17M 10-Q · filed 2019-11-05 | $95.17M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | $0.00 10-K · filed 2020-03-05 | $0.00 10-Q · filed 2019-08-06 | $0.00 derived: sum of 3 quarters · filed 2020-03-05 | $0.00 derived: sum of 4 quarters · filed 2020-03-05 | |
| 2018-03-31 | $0.00 10-K · filed 2020-03-05 | $0.00 derived: sum of 2 quarters · filed 2020-03-05 | $0.00 derived: sum of 3 quarters · filed 2020-03-05 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $0.00 derived: sum of 2 quarters · filed 2020-03-05 | $0.00 10-K · filed 2020-03-05 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |